Warming macrophages to febrile range destabilizes tumor necrosis factor-alpha mRNA without inducing heat shock
- 1 November 1995
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 269 (5) , C1140-C1146
- https://doi.org/10.1152/ajpcell.1995.269.5.c1140
Abstract
We have previously reported that sustained tumor necrosis factor (TNF)-alpha expression is suppressed by temperatures in the febrile range in human macrophages. In this study, we examined the mechanisms of high-temperature-induced macrophage TNF suppression in the RAW 264.7 macrophage cell line. Incubating lipopolysaccharide (LPS)-stimulated RAW 264.7 cells at 40 degrees C reduced TNF secretion by 92% and peak TNF mRNA levels by 43% compared with cells incubated at 37 degrees C (P < 0.05) but did not affect levels of glyceraldehyde-3-phosphate dehydrogenase, beta-actin, or interleukin-6 mRNA. TNF mRNA half-life, measured after transcriptional arrest with actinomycin D, was reduced from 21.8 +/- 3.6 min in LPS-stimulated RAW 264.7 cells at 37 degrees C to 16.0 +/- 1.8 min at 40 degrees C (P < 0.03), but these cells at 40 degrees C did not alter transcription rate or TNF mRNA polysome association. TNF mRNA destabilization occurred at temperatures below the threshold (43 degrees C) for the generalized heat shock response in these cells. We conclude that heating macrophages to febrile-range temperatures attenuates sustained TNF expression by modulating posttranscriptional processing, including acceleration of TNF mRNA decay.Keywords
This publication has 19 references indexed in Scilit:
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Heat shock prevents lipopolysaccharide‐induced tumor necrosis factor‐α synthesis by rat mononuclear phagocytesEuropean Journal of Immunology, 1992
- Application of Transcriptional and Posttranscriptional Reporter Constructs to the Analysis of Tumor Necrosis Factor Gene RegulationThe Lancet Healthy Longevity, 1992
- Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level.The Journal of Experimental Medicine, 1990
- Molecular control of tissue‐specific expression at the mouse TNF locusEuropean Journal of Immunology, 1989
- The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways.Genes & Development, 1989
- GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumorCell, 1988
- Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.The Journal of Experimental Medicine, 1988
- Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin ResistanceScience, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985